Comprehensive medication guide to Pradaxa including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$10–$75 copay for generic Dabigatran (Tier 2–3); brand Pradaxa may require prior authorization and falls on Tier 3–4.
Estimated Cash Pricing
$394–$530/month for brand Pradaxa; generic Dabigatran as low as $45–$200/month with discount cards from GoodRx or SingleCare.
Medfinder Findability Score
72/100
Summarize with AI
On this page
Pradaxa (Dabigatran Etexilate Mesylate) is a prescription blood thinner classified as a direct thrombin inhibitor. It is manufactured by Boehringer Ingelheim Pharmaceuticals and is FDA-approved for several important uses:
Unlike Warfarin, Pradaxa does not require regular blood monitoring (INR checks) or dietary restrictions related to vitamin K intake, making it a more convenient option for many patients.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Pradaxa is a prodrug — meaning the capsule you swallow (Dabigatran Etexilate) gets converted in your body into the active form, Dabigatran. Once active, Dabigatran directly and competitively inhibits thrombin (Factor IIa), a key enzyme in the blood clotting cascade.
Thrombin is responsible for converting fibrinogen into fibrin, which forms the structural framework of blood clots. By blocking thrombin, Pradaxa prevents fibrin formation and reduces the body's ability to form dangerous blood clots in the heart, veins, and arteries.
Important: Capsules must be swallowed whole — do not break, chew, or open them, as this can increase drug absorption by up to 75% and raise the risk of side effects.
75 mg capsules
typically for patients with severe renal impairment (CrCl 15 — 30 mL/min)
110 mg capsules
used for hip replacement prophylaxis and available for dose adjustments
150 mg capsules
the standard dose for most adult indications including atrial fibrillation
Oral pellets (pediatric)
available in 20 mg, 30 mg, 40 mg, 50 mg, 110 mg, and 150 mg for children
Pradaxa (Dabigatran Etexilate) scores a 72 out of 100 on the Medfinder findability scale, meaning it is generally available at most pharmacies with only minor gaps. As of early 2026, Pradaxa is not listed on FDA or ASHP drug shortage databases. Generic Dabigatran has been available since 2023, which has significantly improved supply. However, some patients may encounter intermittent stock issues at individual pharmacies due to distributor allocation or inventory management — not manufacturing shortages.
If your pharmacy is out of stock, try using Medfinder to locate a nearby pharmacy that has it available.
Pradaxa can be prescribed by a range of healthcare providers, including:
Telehealth prescribing is available for Pradaxa, making it accessible for patients who need remote consultations for anticoagulant management.
No. Pradaxa (Dabigatran) is not a controlled substance and has no DEA scheduling. It does not carry a risk of abuse or dependence. You can get refills through standard prescription processes without the additional restrictions that apply to controlled medications.
The most frequently reported side effects include:
Serious side effects to watch for include major or life-threatening bleeding (gastrointestinal or intracranial hemorrhage), spinal/epidural hematoma with neuraxial anesthesia, and increased risk of stroke if the medication is stopped prematurely. Pradaxa carries two FDA boxed warnings regarding premature discontinuation and spinal/epidural hematoma risk. Contact your doctor immediately if you experience unusual bleeding or signs of a blood clot.
Know what you need? Skip the search.
Eliquis (Apixaban)
a Factor Xa inhibitor taken twice daily; generally considered to have the lowest bleeding risk among direct oral anticoagulants (DOACs)
Xarelto (Rivaroxaban)
a Factor Xa inhibitor with convenient once-daily dosing for atrial fibrillation
Savaysa (Edoxaban)
a once-daily Factor Xa inhibitor that requires initial treatment with a parenteral anticoagulant
Warfarin (Coumadin)
the traditional vitamin K antagonist; much cheaper but requires regular INR blood monitoring and dietary restrictions
Prefer Pradaxa? We can find it.
P-gp inhibitors
moderate(Ketoconazole, Dronedarone, Cyclosporine, Itraconazole) — can significantly increase Dabigatran levels; dose reduction or avoidance required
P-gp inducers
moderate(Rifampin, St. John's Wort, Carbamazepine, Phenytoin) — can decrease Dabigatran effectiveness; avoid taking together
Other anticoagulants
moderate(Warfarin, Heparin, Enoxaparin) — significantly increases bleeding risk
Antiplatelet agents
moderate(Aspirin, Clopidogrel, Prasugrel) — increases bleeding risk
NSAIDs
moderate(Ibuprofen, Naproxen) — increases bleeding risk
Verapamil
moderatetake Pradaxa 2 hours before Verapamil to minimize interaction
SSRIs/SNRIs
moderatemay increase bleeding risk
Pradaxa (Dabigatran) remains a trusted and widely prescribed anticoagulant for preventing stroke in atrial fibrillation and treating blood clots. With generic Dabigatran now available, the medication has become more affordable — with prices as low as $45/month using discount cards compared to $394–$530/month for the brand.
The medication scores well on availability (72/100) and can be found at most pharmacies. If your local pharmacy is out of stock, Medfinder can help you quickly locate a pharmacy near you that has it in stock. Its key advantage over Warfarin is the lack of routine blood monitoring and dietary restrictions, though the GI side effects and higher cost (especially for the brand) are trade-offs to consider.
If you're having trouble affording Pradaxa, look into the Boehringer Ingelheim savings card for commercially insured patients or the Boehringer Ingelheim Cares Foundation Patient Assistance Program for uninsured patients (1-800-556-8317).
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards